Ireland
--:--IST
Recruiting Not applicable

Value of Capsular Repair for Latarjet

NCT05978362 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2023-10-11
Last updated
2026-05-13

Condition(s) studied

Shoulder Pain

Investigational drug(s) / intervention(s)

Latarjet technique

Latarjet technique: Realization of a stop according to Latarjet

Study summary

The purpose of the study is to evaluate the occurrence of osteoarthritis (YES/NO) by radiography.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient, male or female, over the age of 18 * Patient with shoulder instability with risk factors for recurrence (ISIS score \> 3), requiring surgical stabilization by abutment * Affiliated patient or beneficiary of a social security scheme * Patient having been informed and having given his free, informed and written consent. Exclusion Criteria: * Patient with history of surgery for instability of the same shoulder * Patient presenting contraindications to the realization of a postoperative scanner * Patient whose physical and/or psychological health is severely impaired, which according to the investigator may affect the compliance of the study participant * Patient participating in another clinical research or in a period of exclusion from another research still in progress at the time of inclusion * Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision * Pregnant, breastfeeding or parturient woman * Patient hospitalized without consent.

Primary outcome measure(s)

  • occurrence of osteoarthritis — 10 years
    Change from occurrence of osteoarthritis (YES/NO) on X-ray at 5 and 10 years, compared to inclusion X-ray using the Samilson-Prieto classification.

Trial sites (1)

FacilityCityRegionStatus
Clinique Maussins-Nollet Paris France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05978362 on ClinicalTrials.gov ↗ ← All trials in France